These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38344913)

  • 1. Association of MUC5B promoter polymorphism with interstitial lung changes after COVID-19: A preliminary observation.
    Dhooria S; Bal A; Sharma R; Prabhakar N; Arora S; Sehgal IS; Kashyap D; Garg M; Bhalla A; Aggarwal AN; Agarwal R
    Indian J Med Res; 2024 Jan; 159(1):109-113. PubMed ID: 38344913
    [No Abstract]   [Full Text] [Related]  

  • 2. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC5B promoter polymorphism and pulmonary fibrosis.
    Zhang GY; Liao T; Gao WY
    N Engl J Med; 2011 Jul; 365(2):178; author reply 178-9. PubMed ID: 21751917
    [No Abstract]   [Full Text] [Related]  

  • 4. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.
    Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA
    Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.
    Wang C; Zhuang Y; Guo W; Cao L; Zhang H; Xu L; Fan Y; Zhang D; Wang Y
    PLoS One; 2014; 9(8):e104919. PubMed ID: 25121989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC5B promoter polymorphism and interstitial lung abnormalities.
    Hunninghake GM; Hatabu H; Okajima Y; Gao W; Dupuis J; Latourelle JC; Nishino M; Araki T; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Murphy E; Steele MP; Loyd JE; Schwarz MI; Fingerlin TE; Rosas IO; Washko GR; O'Connor GT; Schwartz DA
    N Engl J Med; 2013 Jun; 368(23):2192-200. PubMed ID: 23692170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
    Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
    Transpl Int; 2022; 35():10159. PubMed ID: 35651878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the
    Matson SM; Deane KD; Peljto AL; Bang TJ; Sachs PB; Walts AD; Collora C; Ye S; Demoruelle MK; Humphries SM; Schwartz DA; Lee JS
    Am J Respir Crit Care Med; 2022 Feb; 205(4):473-476. PubMed ID: 34874815
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of
    Namba N; Kawasaki A; Sada KE; Hirano F; Kobayashi S; Yamada H; Furukawa H; Shimada K; Hashimoto A; Matsui T; Nagasaka K; Sugihara T; Suzuki A; Yamagata K; Sumida T; Tohma S; Homma S; Ozaki S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N;
    Ann Rheum Dis; 2019 Aug; 78(8):1144-1146. PubMed ID: 30765393
    [No Abstract]   [Full Text] [Related]  

  • 11. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Putman RK; Gudmundsson G; Araki T; Nishino M; Sigurdsson S; Gudmundsson EF; Eiríksdottír G; Aspelund T; Ross JC; San José Estépar R; Miller ER; Yamada Y; Yanagawa M; Tomiyama N; Launer LJ; Harris TB; El-Chemaly S; Raby BA; Cho MH; Rosas IO; Washko GR; Schwartz DA; Silverman EK; Gudnason V; Hatabu H; Hunninghake GM
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28893869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
    Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
    Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.
    Ash SY; Harmouche R; Putman RK; Ross JC; Diaz AA; Hunninghake GM; Onieva Onieva J; Martinez FJ; Choi AM; Lynch DA; Hatabu H; Rosas IO; San Jose Estepar R; Washko GR;
    Chest; 2017 Oct; 152(4):780-791. PubMed ID: 28506611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards clinical significance of the
    Sparks JA
    Ann Rheum Dis; 2021 Dec; 80(12):1503-1504. PubMed ID: 34344705
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
    Adegunsoye A; Vij R; Noth I
    Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in
    Palomäki A; ; Palotie A; Koskela J; Eklund KK; Pirinen M; ; Ripatti S; Laitinen T; Mars N
    Ann Rheum Dis; 2021 Dec; 80(12):1530-1536. PubMed ID: 34344703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between acute respiratory disease events and the
    Ash SY; Harmouche R; Putman RK; Ross JC; Martinez FJ; Choi AM; Bowler RP; Regan EA; Curtis JL; Han MK; Boucher RC; O'Neal WK; Hatabu H; Lynch DA; Rosas IO; Hunninghake GM; San Jose Estepar R; Washko GR;
    Thorax; 2018 Nov; 73(11):1071-1074. PubMed ID: 29440587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedside to gene and back in idiopathic pulmonary fibrosis.
    Cookson WO; Moffatt MF
    N Engl J Med; 2013 Jun; 368(23):2228-30. PubMed ID: 23692168
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
    van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
    Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.